Codeine Still Prescribed To Children Despite Serious Health Risks: Study

Despite recent FDA warnings about the risks associated with the use of codeine among children having their tonsils or adenoids removed, a new report suggests that many doctors continue to prescribe the powerful pain medication for children after tonsillectomy and adenoidectomy procedures. 

Prior research has shown that side effects of codeine pose serious risks for children. While there has been a decline in recent years, a study published in the November issue of the medical journal Pediatrics indicates that too many children continue to receive the drugs.

The FDA launched an investigation in 2012, focusing on the safety of codeine use by children after tonsillectomy or adenoidectomy surgeries. The investigation came after three children died after taking codeine following surgery. As a result, the FDA issued a black box warning in 2013, warning against the use of codeine in children after tonsil or adenoid surgery.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

In this new study, researchers analyzed data involving more than 360,000 children in the Truven MarketScan Commercial Claims and Encounters database, looking at information on children who underwent a tonsillectomy or adenoidecotmy between 2010 to 2015.

The data highlights an overall 13.3% decrease in the proportion of children with more than one prescription filled for codeine after tonsillectomy or adenoidectomy. In January 2010, 31% of children received a prescription for codeine after surgery. By December 2015, that number dropped to 5%. However, that means that many children are still exposed to the dangers of codeine after having their tonsils or adenoids removed.

The FDA investigation into codeine use among children, as well as the black box warning, helped to reduce codeine prescribing overall, however, the data indicates 1 in 20 children who undergo the surgeries are still prescribed codeine. Researchers call this an “unnecessary gamble.”

Another study, conducted after the FDA added the black box warning, indicated more than half a million children are still given codeine for pain every year.

Researchers warn that giving children codeine for pain is especially dangerous. It may not treat their pain and can cause respiratory depression and lead to death. Earlier this year, the FDA issued another warning, calling against codeine and tramadol use for children under the age of 18, especially if they have obstructive sleep apnea, lung disease or other conditions that affect their breathing.

Some children metabolize codeine much more quickly, leading to elevated levels of the active form of the drug reaching their systems much faster. Since 1969, 13 children have overdosed after taking codeine. Eight of those children had undergone tonsillectomy or adenoidectomy and were given the pain medication after surgery.

Researchers also noted the proportion of children receiving alternative opioid painkillers after tonsillectomy or adenoidectomy increased during the study period. It rose from 31.7% in 2010 to 46% by 2015.

Study authors said there was no link between the FDA investigation and the increase. However, in 2015, about 73% of opioids prescribed to children after tonsillectomy were hydrocodone products, 17% were oxycodone, 9% were codeine, and roughly 1% were other opioids.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug
More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug (Posted today)

Plaintiffs and defendants have briefed the new incoming judge on the status of more than 1,200 Valsartan lawsuits ahead of a meeting later this month, which seeks to begin moving the litigation forward following the retirement of the preceding presiding judge.

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 4 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.